DDInter434 DDInter1464
Colistimethate is an antibiotic that has been shown to have bactericidal activity against aerobic gram-negative microorganisms. Colistimethate is particularly indicated when the infection is caused by sensitive strains of Pseudomonas aeruginosa.
Picosulfuric acid is found in laxative products. Sodium picosulfate is a used to treat constipation or induce colon cleansing to prepare the large bowels before colonoscopy or surgery. The combination product containing sodium picosulfate and magnesium citrate was introduced to the Canadian market in 2005 and has been used in European countries for many years.
Colistimethate {u} (Compound) resembles {v} (Compound) Bacitracin
Bacitracin {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Picosulfuric acid
Colistimethate {u} (Compound) resembles {v} (Compound) Polymyxin B
Polymyxin B {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Picosulfuric acid
Colistimethate {u} (Compound) resembles {v} (Compound) Bacitracin
Bacitracin {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Vancomycin
Vancomycin {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Picosulfuric acid
Colistimethate {u} (Compound) resembles {v} (Compound) Colistin
Colistin {u} (Compound) resembles {v} (Compound) Bacitracin
Bacitracin {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Picosulfuric acid
Colistimethate {u} (Compound) resembles {v} (Compound) Polymyxin B
Polymyxin B {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Vancomycin
Vancomycin {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Picosulfuric acid
Colistimethate {u} (Compound) is included by {v} (Pharmacologic Class) Polymyxins
Polymyxins {u} (Pharmacologic Class) includes {v} (Compound) Polymyxin B
Polymyxin B {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Picosulfuric acid
Colistimethate {u} (Compound) resembles {v} (Compound) Colistin
Colistin {u} (Compound) resembles {v} (Compound) Polymyxin B
Polymyxin B {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Picosulfuric acid
Colistimethate {u} (Compound) resembles {v} (Compound) Bacitracin
Bacitracin {u} may lead to a major life threatening interaction when taken with {v} Neomycin
Neomycin {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Picosulfuric acid
Colistimethate {u} (Compound) causes {v} (Side Effect) Protein urine present
Protein urine present {u} (Side Effect) is caused by {v} (Compound) Tramadol
Tramadol {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Picosulfuric acid
Colistimethate {u} (Compound) resembles {v} (Compound) Polymyxin B
Polymyxin B {u} may lead to a major life threatening interaction when taken with {v} Neomycin
Neomycin {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Picosulfuric acid
Colistimethate (Compound) resembles Bacitracin (Compound) and Bacitracin may cause a moderate interaction that could exacerbate diseases when taken with Picosulfuric acid
Colistimethate (Compound) resembles Polymyxin B (Compound) and Polymyxin B may cause a moderate interaction that could exacerbate diseases when taken with Picosulfuric acid
Colistimethate (Compound) resembles Bacitracin (Compound) and Bacitracin may cause a moderate interaction that could exacerbate diseases when taken with Vancomycin and Vancomycin may cause a moderate interaction that could exacerbate diseases when taken with Picosulfuric acid
Colistimethate (Compound) resembles Colistin (Compound) and Colistin (Compound) resembles Bacitracin (Compound) and Bacitracin may cause a moderate interaction that could exacerbate diseases when taken with Picosulfuric acid
Colistimethate (Compound) resembles Polymyxin B (Compound) and Polymyxin B may cause a moderate interaction that could exacerbate diseases when taken with Vancomycin and Vancomycin may cause a moderate interaction that could exacerbate diseases when taken with Picosulfuric acid
Colistimethate (Compound) is included by Polymyxins (Pharmacologic Class) and Polymyxins (Pharmacologic Class) includes Polymyxin B (Compound) and Polymyxin B may cause a moderate interaction that could exacerbate diseases when taken with Picosulfuric acid
Colistimethate (Compound) resembles Colistin (Compound) and Colistin (Compound) resembles Polymyxin B (Compound) and Polymyxin B may cause a moderate interaction that could exacerbate diseases when taken with Picosulfuric acid
Colistimethate (Compound) resembles Bacitracin (Compound) and Bacitracin may lead to a major life threatening interaction when taken with Neomycin and Neomycin may cause a moderate interaction that could exacerbate diseases when taken with Picosulfuric acid
Colistimethate (Compound) causes Protein urine present (Side Effect) and Protein urine present (Side Effect) is caused by Tramadol (Compound) and Tramadol may cause a moderate interaction that could exacerbate diseases when taken with Picosulfuric acid
Colistimethate (Compound) resembles Polymyxin B (Compound) and Polymyxin B may lead to a major life threatening interaction when taken with Neomycin and Neomycin may cause a moderate interaction that could exacerbate diseases when taken with Picosulfuric acid